Self-Reported Side Effects Associated with Selective Androgen Receptor Modulators: A Social Media Data Analysis (Preprint)

Author:

Joshi AdityaORCID,Kaune Diego FedericoORCID,Leff PhillipORCID,Fraser EmilyORCID,Lee SarahORCID,Hazin MoustafaORCID

Abstract

BACKGROUND

Selective Androgen Receptor Modulators (SARMs) are ligands designed for selective anabolic effects on muscle and bone. Despite their original therapeutic intent, SARMs remain unapproved by the FDA and are associated with various toxicities. In recent years, their abuse has increased, particularly among youth targeted through social media.

OBJECTIVE

This study examines adverse symptoms and laboratory data from self-reported social media posts.

METHODS

We conducted a retrospective analysis of public posts on Reddit's SARMs subforums from March 2015 to November 2023. Using Python-based scripts, we extracted posts containing relevant keywords. Data was categorized based on users' self-reported stages of SARMs use. Demographic information, specific SARMs used, concomitant medications, symptoms, and laboratory values were collected.

RESULTS

Of 5,249 extracted posts, 3,877 were included in the analysis. Significant changes in various laboratory parameters were observed across different stages of SARMs use. 17.5% of users reported using Tamoxifen or Enclomiphene, while 7.8% used hepatoprotective supplements.

CONCLUSIONS

The study reveals an alarming increase in SARMs marketing on social media, targeting young adults despite being illegal to sell for human consumption. Many users experienced serious adverse effects, including liver toxicity and hormonal imbalances. Many individuals also self-treated without medical supervision. While the use of self-reported data may affect representativeness, our findings highlight the urgent need for increased awareness and regulation to address the growing public health crisis posed by SARMs abuse. Further research is crucial to uncover the full spectrum of adverse effects, especially in young users vulnerable to misinformation.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3